Five things for pharma marketers to know: Thursday, May 18, 2017


1. If physicians talk to patients about the costs of cancer treatment at all, they spend less than two minutes doing so, according to a new study. Most of the time, that conversation takes place only when patients specifically ask about costs. (AP)

2. Shire plans to file an application for its experimental long-acting treatment for hereditary angioedema with the FDA by early next year. Analysts have said the drug could generate sales of up to $2 billion. (Reuters)

3. Philips CEO Frans van Houten said an obstacle to the adoption of connected devices is insurance coverage. He noted that insurers do not invest as much in prevention as they do in critical care. (Reuters)

4. Just how much does healthcare cost? For a family of four in the U.S., the estimate for 2017 is $26,944, according to data from the 2017 Milliman Medical Index. (Health Populi)

5. The FDA placed a hold on a mid-stage clinical trial underway for Concert Pharma's experimental drug to treat alopecia areata. (Reuters)